AIMDW — Ainos Inc.
NASDAQ · Healthcare · Medical Devices
$0.08
+$0.00 (+0.00%)
Ainos Inc. (AIMDW) is a medical devices company listed on NASDAQ. It is led by Chun-Hsien Tsai, based in 8880 Rio San Diego Drive, San Diego, CA, United States, 92108, with about 44 employees. Ainos, Inc., a dual-platform AI and biotech company, focusing SmellTech, AI diagnostics, and immune therapeutics. Its AI Nose platform uses a smell language model to digitize scent into Smell IDs and turning invisible chemical signals into machine-readable data. The company is also giving AI for robotics, smart factories, senior care, and women's health. In addition, it develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases, plus applications in animal health. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in San Diego, California.
Latest reported AIMDW revenue for 2025-09-30 was $2.2K. Net income was -$2.9M. Revenue was down 53.5% from 2025-06-30 to 2025-09-30.
Use this AIMDW page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the AIMDW quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the AIMDW SEC filings page. Lician reads the product cache first so this HTML stays unique to Ainos Inc. even when a live quote feed is slow.
About Ainos Inc.
Ainos, Inc., a dual-platform AI and biotech company, focusing SmellTech, AI diagnostics, and immune therapeutics. Its AI Nose platform uses a smell language model to digitize scent into Smell IDs and turning invisible chemical signals into machine-readable data. The company is also giving AI for robotics, smart factories, senior care, and women's health. In addition, it develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases, plus applications in animal health. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in San Diego, California.
AIMDW Key Statistics
Market Cap
$0.00M
Previous Close
$0.08
Day Range
$0.08 – $0.08
EPS
-$1.56
Revenue
$20.73K
Net Income
-$14.86M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
-83.0%
Profit Margin
-71702.3%
Employees
44
AIMDW Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $20.73K | $122.11K | $3.52M | $594.56K |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$14.86M | -$13.77M | $14.01M | $3.89M |
| EPS (Diluted) | -$1.56 | -$3.36 | $0.00 | $0.00 |
Total Assets
$28.82M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$3.89M
Operating Cash Flow
-$5.81M
Free Cash Flow
$0.00
Ainos Inc. Company Information
- CEO, President & Chairman of the Board
- Chun-Hsien Tsai
- Headquarters
- 8880 Rio San Diego Drive, San Diego, CA, United States, 92108
- Website
- www.ainos.com
- Phone
- 858 869 2986
- IPO / Founded
- 2022-08-09
- Sector
- Healthcare
- Industry
- Medical Devices